Literature DB >> 2471131

Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.

D A Liebermann1, B Hoffman-Liebermann.   

Abstract

Physiological inducers of myeloid cell growth and differentiation were used to simultaneously analyze the expression of the proto-oncogenes c-myc, c-myb, c-fos, c-fes and c-fms during normal myelopoiesis, where growth is coupled to differentiation, as compared with that in leukemia, where growth has been uncoupled from differentiation as well as upon suppression of the leukemic phenotype via induction of differentiation and growth arrest. Proto-oncogene expression was also used as a tool to dissect the growth to differentiation developmental cascade. Myeloid cell growth was correlated with high c-myc and c-myb RNA levels, decreasing to undetectable levels in terminally differentiated cells. No c-myc RNA was detected in normal myeloid progenitors induced for differentiation without growth, using media conditioned by mouse granulocytes (GCM), indicating that c-myc may play either no role or an inhibitory one in differentiation. RNA levels of the proto-oncogenes c-fos, c-fes and c-fms were undetectable in normal or M1 differentiation inducible (D+) leukemic myeloblasts, and were stably induced upon stimulation of the normal precursors for growth and differentiation, with highest levels at the time when most of the cells had undergone terminal differentiation. Only c-fes RNA was induced upon M1D+ differentiation. It was also shown to be induced upon induction of differentiation without growth in normal myeloid precursors. Using c-myc and c-myb RNA suppression as molecular markers for induction of M1D+ differentiation, the existence of myeloid differentiation factor(s), distinct from myeloid growth factors, has been demonstrated. Such differentiation inducing activity was found in media conditioned by mouse lungs or granulocytes, and was induced in normal myeloid precursors by the myelopoietic growth factors IL3, GM-CSF, G-CSF, and M-CSF. Taken together, the results of this study enhance and add to previous work to better correlate the expression of the proto-oncogenes myc, myb, fes, fos and fms with several parameters of normal and abnormal myeloid cell growth and differentiation. The results indicate that the normal myeloid growth to differentiation developmental cascade entails a mechanism whereby myeloid growth factors induce myeloid differentiation factors, subsequently suppressing c-myc and c-myb RNA expression, leading to the induction of differentiation and growth arrest, including early accumulation of c-fes RNA followed by accumulation of c-fos and c-fms RNAs. It was also indicated that this cascade is impaired in leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471131

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

3.  The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.

Authors:  Joanna Fares; Richard Koller; Rita Humeniuk; Linda Wolff; Juraj Bies
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

4.  Sodium caseinate induces mouse granulopoiesis.

Authors:  V Domínguez-Melendez; O Silvestre-Santana; L Moreno-Fierros; I Aguiñiga-Sánchez; Ledesma Martínez; R Marroquin-Segura; A L García-Hernández; B Weiss-Steider; A Marché-Cova; A Monroy-García; L Mora-García; Edelmiro Santiago-Osorio
Journal:  Inflamm Res       Date:  2012-01-20       Impact factor: 4.575

5.  Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.

Authors:  M Selvakumaran; D A Liebermann; B Hoffman-Liebermann
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 6.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

7.  Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping.

Authors:  Junfang Zhang; Jan Markus; Juraj Bies; Thomas Paul; Linda Wolff
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

8.  Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.

Authors:  M Schmidt; V Nazarov; L Stevens; R Watson; L Wolff
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells.

Authors:  K Krishnaraju; H Q Nguyen; D A Liebermann; B Hoffman
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

10.  Characterization of the FB-NOF transposable element of Drosophila melanogaster.

Authors:  N Harden; M Ashburner
Journal:  Genetics       Date:  1990-10       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.